Publication | Closed Access

Therapeutic effects of leflunomide, a new antirheumatic drug, on glomerulonephritis induced by the antibasement membrane antibody in rats

Glomerular DiseaseImmunologyTherapeutic EffectsInflammationGlomerulonephritisIga GlomerulonephritisInflammatory Rheumatic DiseaseChronic Kidney DiseaseRheumatoid ArthritisRheumatologyAutoimmune DiseaseLupus NephritisAutoimmunityPharmacologyAntibasement Membrane AntibodyAnti-inflammatoryMedicineNephrologyNew Antirheumatic Drug